Six new 5-(1-/2-naphthyloxymethyl)-1,3,4-oxadiazole-2(3H)-thione, 2-amino-5-(1-/2-naphthyloxymethyl)-1,3,4-oxadiazole, 5-(1-/2-naphthyloxymethyl)-1,3,4-oxadiazole-2(3H)-one derivatives have been synthesized from 1-and/or 2-naphthol. The structures of the compounds were confirmed by IR and 1H NMR spectral data and microanalysis. The antimicrobial properties of the compounds were investigated against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, Candida albicans, C. krusei and C. parapsilosis using microbroth dilution method. 2-Amino-5-(2-naphthyloxymethyl)-1,3,4-oxadiazole and 5-(2-naphthyloxymethyl)-1,3,4-oxadiazole-2(3H)-one show significantly (32 microg/ml), compounds 5-(1-/2-naphthyloxymethyl)-1,3,4-oxadiazole-2(3H)-thione, 2-amino-5-(1-naphthyloxymethyl)-1,3,4-oxadiazole and 5-(1-naphthyloxymethyl)-1,3,4-oxadiazole-2(3H)-one moderately (64 microg/ml) active against C. krusei. All the compounds were active against S. aureus, E. coli, P. aeruginosa, C. albicans, and C. parapsilosis at 64-256 microg/ml concentration.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-827x(02)01245-4DOI Listing

Publication Analysis

Top Keywords

synthesis antimicrobial
4
antimicrobial activity
4
activity 134-oxadiazole
4
134-oxadiazole derivatives
4
derivatives 5-1-/2-naphthyloxymethyl-134-oxadiazole-23h-thione
4
5-1-/2-naphthyloxymethyl-134-oxadiazole-23h-thione 2-amino-5-1-/2-naphthyloxymethyl-134-oxadiazole
4
2-amino-5-1-/2-naphthyloxymethyl-134-oxadiazole 5-1-/2-naphthyloxymethyl-134-oxadiazole-23h-one
4
5-1-/2-naphthyloxymethyl-134-oxadiazole-23h-one derivatives
4
derivatives synthesized
4
synthesized 1-and/or
4

Similar Publications

Canine urothelial cell model to study intracellular bacterial community development by uropathogenic Escherichia coli.

PLoS One

January 2025

Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America.

Urinary tract infections (UTIs) are among the most common bacterial infections of both dogs and humans, with most caused by uropathogenic Escherichia coli (UPEC). Recurrent UPEC infections are a major concern in the treatment and management of UTIs in both species. In humans, the ability of UPECs to form intracellular bacterial communities (IBCs) within urothelial cells has been implicated in recurrent UTIs.

View Article and Find Full Text PDF

Multiplicity of type 6 secretion system toxins limits the evolution of resistance.

Proc Natl Acad Sci U S A

January 2025

Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9NT, United Kingdom.

The bacterial type 6 secretion system (T6SS) is a toxin-injecting nanoweapon that mediates competition in plant- and animal-associated microbial communities. Bacteria can evolve de novo resistance against T6SS attacks, but resistance is far from universal in natural communities, suggesting key features of T6SS weaponry may act to limit its evolution. Here, we combine ecoevolutionary modeling and experimental evolution to examine how toxin type and multiplicity in attackers shape resistance evolution in susceptible competitors.

View Article and Find Full Text PDF

Background: Approximately 6.7 million people in the US are diagnosed with an Alzheimer's disease (AD), with greater incidence in women and minorities. Approximately 11 million family members provide uncompensated care to their family members with dementia, with more than 60% reporting high or very high levels of stress, a condition associated with increased risk for AD.

View Article and Find Full Text PDF

Background: Peripheral blood mononuclear cells (PBMCs) were obtained from patients across different stages of Parkinson's disease (PD) progression and stimulated ex vivo to develop biomarkers for predicting PD progression.

Method: PBMCs obtained at one time-point from patients with moderate stage PD (>5 years after diagnosis) (n = 30), early stage PD (<5 years after diagnosis) (n = 27), prodromal PD (rapid-eye-movement sleep behavior disorder patients) (n = 14), and healthy controls (HCs) (n = 9) were isolated from whole blood and cryopreserved. Samples were thawed, then pan-monocytes and T-cell populations were isolated from PBMCs and subjected to treatment with vehicle or IFN-γ.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Affiliated Drum Tower Hospital of Medical School, Nanjing University, NANJING, Jiangsu, China.

Background: Alzheimer's disease (AD) is associated with abnormal glucose tolerance. However, the contributing factors are unknown. We aim to find markers of Alzheimer's disease in association with abnormal glucose tolerance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!